A. Arcocha

Multiplex RNA‐based detection of clinically relevant MET alterations in advanced non‐small cell lung cancer

R. Rosell, N. Viñolas, A. Prat, 2020, Molecular oncology.

Prospective Evaluation of Single Nucleotide Variants by Two Different Technologies in Paraffin Samples of Advanced Non-Small Cell Lung Cancer Patients

P. Jares, N. Viñolas, N. Reguart, 2020, Diagnostics.

A Pilot Study to Evaluate Early Predictive Value of Thorax Perfusion-CT in Advanced NSCLC

Marcelo Sánchez, M. Benegas, I. Vollmer, 2021, Cancers.

Usefulness of Two Independent DNA and RNA Tissue-Based Multiplex Assays for the Routine Care of Advanced NSCLC Patients

P. Jares, Marcelo Sánchez, I. Vollmer, 2020, Cancers.

Molecular characterization of advanced non-small cell lung cancer patients by cfDNA analysis: experience from routine laboratory practice

P. Jares, N. Viñolas, N. Reguart, 2021, Journal of thoracic disease.

Technical Evaluation of the COBAS EGFR Semiquantitative Index (SQI) for Plasma cfDNA Testing in NSCLC Patients with EGFR Exon 19 Deletions

P. Jares, N. Reguart, J. Puig-Butillé, 2021, Diagnostics.

Prevalence of incidental pathogenic germline variants detected in cfDNA in patients with oncogene-driven non-small cell lung cancer.

N. Viñolas, A. Prat, N. Reguart, 2022, Journal of Clinical Oncology.